From Chronic to Acute Models of Heart Failure – The Cost-Effectiveness Perspective

1. Liao L, Allen LA, Whellan DJ. Economic burden of heart failure in the elderly. Pharmacoeconomics. 2008;26:447-462. doi:10.2165/00019053-200826060-00001.10.2165/00019053-200826060-00001Open DOISearch in Google Scholar

2. Stewart S, Jenkins A, Buchan S. The current cost of heart failure to the National Health Service in the UK. Eur J Heart Fail. 2002;4:361-371. doi: 10.1016/s1388-9842(01)00198-2.10.1016/s1388-9842(01)00198-2Open DOISearch in Google Scholar

3. Lesyuk W, Kriza C, Kolominsky-Rabas P, et al. Cost-of-illness studies in heart failure: a systematic review 2004–2016. BMC Cardiovasc Disord. 2018;18:74. doi: 10.1186/s12872-018-0815-3.10.1186/s12872-018-0815-3Open DOISearch in Google Scholar

4. Ponikowski P, Anker SD, AlHabib KF, et al. Heart failure: preventing disease and death worldwide. ESC Heart Fail. 2014;1:4-25. doi: 10.1002/ehf2.12005.10.1002/ehf2.12005Open DOISearch in Google Scholar

5. Kilgore M, Patel HK, Kielhorn A, Maya JF, Sharma P. Economic burden of hospitalizations of Medicare beneficiaries with heart failure. Risk Manag Healthc Policy. 2017;10:63-70. doi: 10.2147/RMHP.S130341.10.2147/RMHP.S130341Search in Google Scholar

6. Cook C, Cole G, Asaria P, Jabbour R, Francis DP. The annual global economic burden of heart failure. Int J Cardiol. 2014;171:368-376. doi: 10.1016/j.ijcard.2013.12.028.10.1016/j.ijcard.2013.12.028Open DOISearch in Google Scholar

7. Dunlay SM, Shah ND, Shi Q, et al. Lifetime costs of medical care after heart failure diagnosis. Circ Cardiovasc Qual Outcomes. 2011;4:68-75. doi: 10.1161/CIRCOUTCOMES.110.957225.10.1161/CIRCOUTCOMES.110.957225Open DOISearch in Google Scholar

8. Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation. 2014;129:e28-e292. doi: 10.1161/01.cir.0000441139.02102.80.10.1161/01.cir.0000441139.02102.80Search in Google Scholar

9. Reed SD, Whellan DJ, Li Y, et al. Economic evaluation of the HF-ACTION (Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training) randomized controlled trial: an exercise training study of patients with chronic heart failure. Circ Cardiovasc Qual Outcomes. 2010;3:374-381. doi: 10.1161/CIRCOUTCOMES.109.907287.10.1161/CIRCOUTCOMES.109.907287Open DOISearch in Google Scholar

10. Ranasinghe I, Wang Y, Dharmarajan K, et al. Readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia among young and middle-aged adults: a retrospective observational cohort study. PLoS Med. 2014;11:e1001737. doi: 10.1371/journal.pmed.1001737.10.1371/journal.pmed.1001737Search in Google Scholar

11. Ishani A, Weinhandl E, Zhao Z, et al. Angiotensin-converting enzyme inhibitor as a risk factor for the development of anemia, and the impact of incident anemia on mortality in patients with left ventricular dysfunction. J Am Coll Cardiol. 2005;45:391-399. doi: 10.1016/j.jacc.2004.10.038.10.1016/j.jacc.2004.10.038Open DOISearch in Google Scholar

12. Anand IS, Kuskowski MA, Rector TS, et al. Anemia and change in hemoglobin over time related to mortality and morbidity in patients with chronic heart failure: results from Val-HeFT. Circulation. 2005;112:1121-1127. doi: 10.1161/CIRCULATIONAHA.104.512988.10.1161/CIRCULATIONAHA.104.512988Open DOISearch in Google Scholar

13. Komajda M, Anker SD, Charlesworth A, et al. The impact of new onset anaemia on morbidity and mortality in chronic heart failure: results from COMET. Eur Heart J. 2006;27:1440-1446. doi: 10.1093/eurheartj/ehl012.10.1093/eurheartj/ehl012Open DOISearch in Google Scholar

14. Kitta Y, Obata JE, Nakamura T, et al. Persistent impairment of endothelial vasomotor function has a negative impact on outcome in patients with coronary artery disease. J Am Coll Cardiol. 2009;53:323-330. doi: 10.1016/j.jacc.2008.08.074.10.1016/j.jacc.2008.08.074Open DOISearch in Google Scholar

15. Lorenzovici L, Szekely A, Farkas-Raduly S, Jitaru C, Csanadi M. Budget Impact of Intravenous Iron Therapy with Ferric Carboxymaltose in Patients with Chronic Heart Failure and Iron Deficiency in Romania. Journal of Cardiovascular Emergencies. 2019;5:131-139. doi: 10.2478/jce-2019-0018.10.2478/jce-2019-0018Open DOISearch in Google Scholar

16. Rusu ERG, Tartau LM, Statescu C, et al. Study of Dynamics of Immunobiochemical Parameters and Pharmacological Interferences in the Metabolic Syndrome. Revista de Chimie. 2018;69:1493-1497.10.37358/RC.18.6.6353Search in Google Scholar